Clear-cell papillary renal-cell carcinoma (CCPC) and acquired cystic kidney disease-associated carcinoma (ACDAC) are neoplasms with distinct morphological characteristics that behave less aggressively than conventional renal-cell carcinomas. End-stage kidney specimens from 61 patients (47 males and 14 females) with 109 renal-cell carcinomas were selected. Papillary renal-cell carcinoma was the most common malignancy (61/109, 56%), followed by CCPC (20/109, 18%). The CCPC showed a papillary or tubular/solid architecture, clear cytoplasm, low nuclear grade, and a distinct immunohistochemical profile (RCC−, vimentin+, CK7+, p504S−). ACDAC displayed a variety of architectural patterns, eosinophilic cytoplasm, high nuclear grade, intratumoral calcium oxalate deposits, and an immunohistochemical profile similar to type 2 papillary renal-cell carcinoma (RCC+, vimentin+, CK7−/+, p504S+). Less than 5% (3/69) of pathologically staged renal-cell carcinomas in end-stage kidneys presented with lymphogenous and/or hematogenous metastases.
TruongLDKrishnanBCaoJTBarriosRSukiWN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis. 1995;26:1-12.
2.
BonsibSM. Renal cystic disease and renal neoplasms: a mini review. Clin J Am Soc Nephrol. 2009;4:1998-2007.
3.
HughsonMDMeloniAMSilvaFGSandbergAA. Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings. Cancer Genet Cytogenet. 1996;89:65-68.
4.
HoshidaYNakanishiHShinMSatohTHanaiJAozasaK. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations. Transplantation. 1999;68:385-390.
5.
SavajSLiakopoulosVGhareebS. Renal cell carcinoma in peritoneal dialysis patients. Int Urol Nephrol. 2003;35:263-265.
6.
DentonMDMageeCCOvuworieC. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002;61:2201-2209.
7.
HughsonMDBuchwaldDFoxM. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med. 1986;110:592-601.
8.
DunnillMSMillardPROliverD. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977;30:868-877.
9.
MatsonMACohenEP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990;69:217-226.
10.
Farivar-MohseniHPerlmutterAEWilsonSShingletonWBBiglerSAFowlerJEJr. Renal cell carcinoma and end stage renal disease. J Urol. 2006;175:2018-2020.
11.
SatohSTsuchiyaNHabuchiTIshiyamaTSeimoKKatoT. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J Urol. 2005;174:1749-1753.
12.
RiveraMTickooSKSaqiALinO. Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases. Diagn Cytopathol. 2008;36:344-347.
13.
TickooSKdePeralta-VenturinaMNHarikLR. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153.
14.
SuleNYakupogluUShenSS. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29:443-451.
15.
Cossu-RoccaPEbleJNZhangSMartignoniGBrunelliMChengL. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006;19:780-787.
GobboSEbleJNGrignonDJ. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
18.
GobboSEbleJNMaclennanGT. Renal cell carcinoma with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol. 2008;32:1780-1786.
19.
Rioux-LeclercqNCEpsteinJI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch Pathol Lab Med. 2003;127:E89-E92.
20.
EbleJNSauterGEpsteinJISesterhennIA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004.
21.
DelahuntBSika-PaotonuDBethwaitePB. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007;31:957-960.
HughsonMDSchmidtLZbarB. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol. 1996;7:2461-2468.
24.
KlatteTSaidJWSeligsonDB. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell featuresJ Urol. 2011;185:30-36.
25.
MaiKTFarajiHDesantisDRobertsonSJBelangerECLevacJ. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study. Virchows Arch. 2010;456:77-84.
26.
DelahuntBEbleJN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544.
27.
DrySMRenshawAA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch Pathol Lab Med. 1998;122:260-261.
28.
Zamin-KhamehNZhaiQTruongLD. Renal cell carcinoma with calcium oxalate deposition: a distinct type of renal cell carcinoma within the spectrum of renal neoplasms associated with acquired cystic kidney disease. Pathol Case Rev. 2010;15:14-19.
29.
KovacsG. High frequency of papillary renal-cell tumours in end-stage kidneys: is there a molecular genetic explanation?Nephrol Dial Transplant. 1995;10:593-596.
30.
HesOSimaRNemcovaJ. End-stage kidney disease: gains of chromosome 7 and 17 and loss of Y chromosome in non-neoplastic tissue. Virchows Arch. 2008;453:313-319.
31.
HughsonMDBiglerSDickmanKKovacsG. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol. 1999;12:301-309.
32.
KurodaNShiotsuTHesOMichalMShuinTLeeGH. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol. 2010;43:231-234.
